Head & Neck/Thyroid Cancers
News
Few new cancer drugs replace current standards of care
Newer drugs could benefit patients but could increase the cost of care.
Latest News
Ways to lessen toxic effects of chemo in older adults
Three recent high-quality randomized trials evaluated the use of geriatric assessment in older adults with cancer.
News
Radioactive iodine shows no benefit in low-risk thyroid cancer
The study’s take-home message for clinicians should be to “stop systematic radioiodine ablation administration in low-risk thyroid cancer patients...
Conference Coverage
Can liquid biopsy predict oropharyngeal cancer recurrence?
Latest News
Radiofrequency ablation an option for thyroid microcarcinoma
RFA might be a good option for high risk surgical patients and patients who forgo active surveillance.
Latest News
Nedaplatin chemo proves to be a less toxic option for nasopharyngeal carcinoma
Chemotherapy-induced toxic effects, such as renal dysfunction, have always been a major concern in nasopharyngeal carcinoma.
News
Brain tumors exact higher mortality toll in men than women
“We cannot discount the role of sex differences in diagnosis, treatment, or behavioral risk factors that may underlie the better survival for...
Opinion
“I didn’t want to meet you.” Dispelling myths about palliative care
This is the first installment of “Diminutio,” a column by Sarah D’Ambruoso, NP, a palliative care nurse in oncology. Today, she shares stories...
Latest News
Confirmed: Pembro plus chemo as first-line standard of care for esophageal cancer
An interim analysis of KEYNOTE-590 found that the combination of pembrolizumab and chemotherapy as first-line treatment, proved superior to...
News
Severe COVID two times higher for cancer patients
